Kidney Week

Abstract: FR-PO073

Multisystemic Support Therapies for AKI in Latin America: Current Status and Preliminary Report

Session Information

• AKI: Epidemiology, Risk Factors, and Prevention - 2
  October 25, 2024 | Location: Exhibit Hall, Convention Center
  Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

• 101 AKI: Epidemiology, Risk Factors, and Prevention

Authors

• Rizo Topete, Lilia Maria, Hospital Universitario "Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico

Lilia Maria Rizo Topete, MD

• Jimenez Acosta, Dario Xavier, Hospital Enrique Garces, Quito, Pichincha, Ecuador

Dario Xavier Jimenez Acosta, MD

• Claure-Del Granado, Rolando, Universidad Mayor de San Simon, Cochabamba, Cochabamba, Bolivia, Plurinational State of

Rolando Claure-Del Granado, MD, FASN

• Vega, Olynka, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Ciudad de México, Mexico

Olynka Vega, MD, MS

• Molano-Triviño, Alejandra, Fundacion Cardioinfantil Instituto de Cardiologia, Bogota, Colombia

Alejandra Molano-Triviño, DrMed

• Ponce, Daniela, Universidade de Sao Paulo Instituto de Ciencias Biomedicas, Sao Paulo, São Paulo, Brazil

Daniela Ponce, PhD

• Ballesteros Castro, David Andres, Universidad del Cauca, Popayan, Colombia

David Andres Ballesteros Castro, APN

Group or Team Name

• SLANH AKI and Blood Purification Committee.

Background

Kidney replacement therapy (KRT), including extracorporeal organ support (ECOS), is vital for treating acute kidney injury (AKI). Understanding available resources is crucial. Therefore, the Acute Kidney Injury Committee of the Latin American Society of Nephrology and Hypertension (SLANH) surveyed to gather information on human resources and equipment for KRT/ECOS treatment of AKI in Latin America.

Methods

A 30-question survey form was created to assess KRT/ECOS characteristics, including human resources, equipment, and types of procedures. Conducted online using Google Forms®, the survey was available for four months.

Results

325 responses were collected, 89% from nephrologists. Among the nephrologists, 38% were women, and the main age group was 35-45 years. Participants were from 18 countries, with the highest responses from Mexico (29%), Ecuador (15%), and Colombia (13%). The survey highlighted the need for more training in CRRT (50%), ECMO (53%), ECCO2R (47.6%), TPE (46%), and HA (53%). Notably, 80% of participants' hospitals lacked ECMO. The most available therapies were IHD, CRRT, and PD, with the most common machines being IHD, PD, and CRRT. Only 42% could perform TPE, and 28% could provide other liver support therapies, with hemoadsorption available to only 23%. Nephrologists were responsible for prescribing therapies in 80% of cases, with joint decisions in 15%. The most frequent indication was fluid overload (30%), followed by uremic syndrome (26%) and oliguria (24%). Heparin was the most used anticoagulant for CRRT in Latin America (72%).

Conclusion

The lack of statistics in our region is a reality, but the shortage of technologies, equipment, and opportunities for patients and trainees is overwhelming. The new era of renal replacement therapies, like CRRT as a platform for other ECOS therapies, is in the hands of young nephrologists who need support and training.